Headline News about Rezolute, Inc. - Common Stock (NV)
FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment
September 09, 2024
Via Benzinga
Exposures
Product Safety
Via Benzinga
Analyst Expectations for Rezolute's Future
November 14, 2023
Via Benzinga
Expert Ratings for Rezolute
September 18, 2023
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 23, 2024
Via Benzinga
$17M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
March 20, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
$1.5M Bet On This Penny Stock? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying
March 11, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Lumen Technologies And 3 Other Stocks Under $3 Insiders Are Buying
February 28, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying
February 22, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Rezolute And 3 Other Penny Stocks Insiders Are Buying
February 21, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
December 20, 2023
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Stocks That Hit 52-Week Lows On Monday
October 02, 2023
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.